mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.03 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.03 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.12 |
0.03 |
mRNA |
DMOG |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.03 |
mRNA |
FMK |
GDSC1000 |
pan-cancer |
AAC |
-0.081 |
0.03 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.03 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.03 |
mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
-0.064 |
0.03 |
mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.03 |